Abstract: A series of 1,3,4-oxadiazole derivatives with significant broad-spectrum anticancer activity against different
INTRODUCTION

26
Telomerase, a reverse transcriptase, maintains telomere and chromosomes integrity of dividing cells, while it is 27 inactivated in most somatic cells (1, 2) . In tumor cells, telomerase is highly activated, and works in order to maintain 28 the length of telomeres causing immortality, hence it could be considered as a potential marker to tumorigenesis (3-29 5). The great advantage of targeting this reverse transcriptase, with respect to other cancer targets, is due to its strict 30 specificity for cancer cells. In fact, it is expressed in up to the 90% of cancers (6,7). Human telomerase consists of two 31 portions: a template-encoding RNA (TER), and a reverse transcriptase part (TERT) which also consists of an essential 32 N-terminal domain (TEN), a telomerase RNA binding domain (TRBD), a reverse transcriptase domain (RT), and a 33 C-terminal domain (8, 9) . In the past decades, several classes of inhibitors were identified: oligonucleotides targeting 34 the telomerase RNA templates (10), compounds targeting telomeric DNA(11), nucleosidic transcriptase inhibitors
35
(12) and G-quadruplex stabilizing compounds as telomerase inhibitors (13, 14) . Among this range of compounds' 36 classes, different substituted 1,3,4-oxadiazoles showed potent anti-tumor activities (15) (16) (17) (18) , and in particular 37 telomerase inhibitory activity (18, 19) . Moreover, oxazole, bioisoster of 1,3,4-oxadiazole ring, is the scaffold of 38 telomestatin, which is a natural product isolated from Streptomyces anulatus, with potent telomerase inhibitory activity 39 (20) . The emphasis of recent efforts to develop new telomerase inhibitors has been focused on structure-based design 40 (18, 19, (21) (22) (23) 
86
Dataset was randomly split into a training set (19 compounds) for model generation, and a prediction set ( 5 87 compounds) for the validation of developed models, as reported in Table 1 . First, the models were generated by the 88 all-subset procedure with two variables, and subsequently by using genetic algorithm (GA) up to three variables,
89
respecting the objects/descriptors ratio ≥ 5 (27). We used the most common and transparent method, where models 
93
Models validation
94
The generated models were measured according to appropriate measures of goodness-of-fit, robustness, and predictive 98
Where � are the actual and predicted activities of the ith molecule, respectively, and � is the average activity of 100 all molecules.
101
Predictive capability of the models generated was assessed by means of the external validation of the prediction set.
102
Used statistics for external validation are: Q 
119
Prediction capability of modeled properties for the whole universe of chemicals is still not expected, even if robust 120 and validated models are developed (42). QSAR models must be verified for their applicability domain, the latter
121
having the ability to provide predicted data for compounds that are similar to chemicals used to generate the model.
122
The applicability domain of the model was verified by the leverage approach, and fixed thresholds have been used to 
126
(h*) where p' is the number of model variables plus one, and n is the number of the objects used to calculate the model.
128
RESULTS AND DISCUSSION
129
For the development of the QSAR models for 1,3,4-oxadiazole derivatives, MLR with OLS was applied. Initially, we 130 generated models considering only one descriptor, then, we extended the calculation to two variables using the "all- 
141
In Figure 1 is shown the plot of experimental versus calculated endpoint. 142 
153
In terms of applicability domain, one structural outlier has been identified (compound #10) based on h*=0.632 ( Figure   154 2). 
165
In Figure 3 the plot of experimental versus calculated endpoint for model 2 is shown.
166
Figure 3 the plot of experimental versus calculated endpoint for model 2
168
Model 2 is also represented by a three parametric expression, and it was obtained using the same method of model 1.
169
Model 2 has measures of fitness above the optimal thresholds too, and it shows an internal predictive power of 72%
170
(Q 2 = 0.72), with a very low probability of random correlation among activity values and independent variables (R 
176
In terms of applicability domain, the same structural outlier of model 1 has been identified (compound #10) based on 177 h*=0.632 (Figure 4) . 
203
All the three models identified showed good parameters of fitness, robustness and predictive capability. They differ Table 2 , predicted and residuals for the three QSAR models are reported. In Table 3 
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